Skip to content
naulon
Not checkedNot checked for notices yet.

A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer

Slotman Ben J, Vincent Andrew, Lagerwaard Frank J and 3 more

Radiation Oncology · 2006

doi:10.1186/1748-717x-1-8 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

<p>Abstract</p> <p>Background</p> <p>Respiration-gated radiotherapy can permit the irradiation of smaller target volumes. 4DCT scans performed for routine treatment were retrospectively analyzed to establish the benefits of gating in stage III non-small cell lung cancer (NSCLC).</p> <p>Materials and methods</p> <p>Gross tumor volumes (GTVs) were contoured in all 10 respiratory phases of a 4DCT scan in 15 patients with stage III NSCLC. Treatment planning was performed using different planning target volumes (PTVs), namely: (i) PTV<sub>routine</sub>, derived from a single GTV plus 'conventional' margins; (ii) PTV<sub>all phases </sub>incorporating all 3D mobility captured by the 4DCT; (iii) PTV<sub>gating</sub>, incorporating residual 3D mobility in 3–4 phases at end-expiration. Mixed effect models were constructed in order to estimate the reductions in risk of lung toxicity for the different PTVs.</p> <p>Results</p> <p>Individual GTVs ranged from 41.5 – 235.0 cm<sup>3</sup>. With patient-specific mobility data (PTV<sub>all phases</sub>), smaller PTVs were derived than when 'standard' conventional margins were used (p < 0.001). The average residual 3D tumor mobility within the gating window was 4.0 ± 3.5 mm, which was 5.5 mm less than non-gated tumor mobility (p < 0.001). The reductions in mean lung dose were 9.7% and 4.9%, respectively, for PTV<sub>all phases </sub>versus PTV<sub>routine</sub>, and PTV<sub>gating </sub>versus PTV<sub>all phases</sub>. The corresponding reductions in V<sub>20 </sub>were 9.8% and 7.0%, respectively. Dosimetric gains were smaller for primary tumors of the upper lobe versus other locations (p = 0.02). Respiratory gating also reduced the risks of radiation-induced esophagitis.</p> <p>Conclusion</p> <p>Respiration-gated radiotherapy can reduce the risk of pulmonary toxicity but the benefits are particularly evident for tumors of the middle and lower lobes.</p>

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.